
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
   <TITLE>Lexaria Bioscience Corp.: Exhibit 10.1 - Filed by newsfilecorp.com</TITLE>
   <META name="HandheldFriendly" content="true">
</HEAD>

<BODY style="font-size:10pt;">

<HR noshade align="center" width=100% size=3 color="black">
<!--$$/page=--><A name=page_1></A>
<P align=justify><B><U>Legend:</U></B><B> </B></P>
<P align=justify>Certain parts of this document have not been disclosed and have 
been filed separately with the Secretary of the Securities and Exchange 
Commission, and are subject to a confidential treatment request pursuant to Rule 
406 of the Securities Exchange Act of 1933. These sections have been marked with 
asterisks (ie. &#147;********&#148;). For following information has been removed: </P>
<DIV>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
borderColor=#000000 cellSpacing=0 cellPadding=3 width="100%" border=1>
  
  <TR vAlign=top>
    <TD align=left noWrap bgcolor="#eeeeee">&nbsp; </TD>
    <TD width="65%" align=left noWrap bgcolor="#eeeeee"><B><U>Terms or Type of Term(s)</U></B> 
    </TD>
    <TD width="30%" align=left noWrap bgcolor="#eeeeee"><B><U>Section:</U></B> </TD></TR>
  <TR vAlign=top>
    <TD align=left>1. </TD>
    <TD align=left width="65%">Identifying information of a party to the 
      Licensing Agreement </TD>
    <TD align=left width="30%">Page 1 &#150; 1<SUP>st </SUP>paragraph <BR><BR>Page 
      1 &#150; Recitals <BR><BR>Page 10 &#150; Section 14 <BR><BR>Page 11 &#150; Section 20 
      <BR><BR>Page 14 &#150; Signature </TD></TR>
  <TR vAlign=top>
    <TD align=left>2. </TD>
    <TD align=left width="65%">Subject matter of Licensing Agreement </TD>
    <TD align=left width="30%">Page 1 &#150; Recitals <BR><BR>Page 2 &#150; Section 1(b) 
      and 1(c) <BR><BR>Page 3 &#150; Section 2(a) <BR><BR>Exhibit B <BR><BR>Exhibit C 
      &#150; Section (b)(i) </TD></TR>
  <TR vAlign=top>
    <TD align=left>3. </TD>
    <TD align=left width="65%">Terms regarding exclusivity and duration of 
      license and License Option </TD>
    <TD align=left width="30%">Page 3 &#150; Section 2(a)(i) and (ii) <BR><BR>Page 
      3 &#150; Section 2(c) </TD></TR>
  <TR vAlign=top>
    <TD align=left>4. </TD>
    <TD align=left width="65%">Rights to improvements on license and/or 
      intellectual property </TD>
    <TD align=left width="30%">Page 4 &#150; Section 3(c)(ii) and (iii) 
      <BR><BR>Page 5 &#150; Section 3(e)(i) and (ii) </TD></TR>
  <TR vAlign=top>
    <TD align=left>5. </TD>
    <TD align=left width="65%">Material compensation terms of the Licensing 
      Agreement </TD>
    <TD align=left width="30%">Page 7 &#150; Section 4(d) <BR><BR>Page 7 &#150; Section 
      5(a) and (b) <BR><BR>Exhibit C &#150; Section (a) and (b) 
</TD></TR></TABLE></DIV><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A>
<P align=center><B>INTELLECTUAL PROPERTY LICENSE AGREEMENT</B> </P>
<P align=justify style="text-indent:5%">This Intellectual Property License Agreement (this 
&#147;<B>Agreement</B>&#148;) dated as of May 14, 2016 (the &#147;<B>Effective Date</B>&#148;) is 
made by and between Lexaria Bioscience Corp., a Nevada corporation with offices 
at 950, 1130 W. Pender Street, Vancouver, British Columbia, V6E 4A4, Canada 
(&#147;<B>Licensor</B>&#148;), and ******* (&#147;<B>Licensee</B>&#148;). LICENSOR and LICENSEE are 
sometimes referred to individually herein as a &#147;<B>Party</B>&#148; and collectively 
as the &#147;<B>Parties</B>&#148;. </P>
<P align=center><B>RECITALS</B> </P>
<P align=justify style="text-indent:5%">WHEREAS, LICENSEE is directly or indirectly through a Partner, 
as further defined in section 1(a), engaged in the business of developing, 
manufacturing, and selling marijuana-infused products pursuant to licenses 
issued by the State of Colorado Department of Revenue Marijuana Enforcement 
Division (&#147;<B>MED</B>&#148;), pursuant to regulations promulgated under C.R.S. &#167; 
12-43.4 -101 <I>et seq</I>, and the City of *******&nbsp; pursuant to regulations 
promulgated thereby; </P>
<P align=justify style="text-indent:5%">WHEREAS, LICENSOR owns and holds certain intellectual property 
and technology related to, including but not limited to, the development, 
testing, and manufacturing process for marijuana-infused products 
(&#147;<B>Technology</B>&#148;), which Technology is more specifically described in 
<U>Exhibit </U>A and detailed batch records and formulation calculation 
spreadsheets provided by email on March 23, 2016, by LICENSOR to LICENSEE; </P>
<P align=justify style="text-indent:5%">WHEREAS, LICENSEE wishes to utilize the Technology from 
LICENSOR, and LICENSOR desires for LICENSEE to utilize the Technology, to 
create, test, manufacture and sell marijuana-infused ******* products with or without 
the addition of hemp or products using derivatives of either the marijuana or 
hemp plants to create consumable and/or topical products that will always 
contain some ******* (<B>&#147;End Products&#148;</B>) subject to the terms and conditions set 
forth herein. Such End Products shall only be distributed and/or sold by 
LICENSEE or Partner as defined in Section 1.a below to the following permitted 
locations (<B>&#147;Permitted Locations&#148;</B>): properly licensed medical marijuana 
dispensaries, retail marijuana stores, and marijuana delivery services that are 
in compliance with all local and state licensing requirements applicable to the 
marijuana industry within the State of Colorado or in any other state in which 
LICENSEE is permitted by this Agreement or an addendum to the same to sell or 
distribute the End Products further, the End Products are specifically 
prohibited from sale by LICENSEE to or through any pharmacies, convenience 
stores, grocery stores, fitness clubs and other similar traditional retail and 
wholesale locations. The End Products will be classified into Product Lines 
(&#147;<B>Product Lines</B>&#148;) as further defined in Section 1. </P>
<P align=justify style="text-indent:5%">NOW, THEREFORE, in consideration of the promises and the 
respective covenants and agreements of the parties contained in this Agreement, 
the Parties hereto agree as follows: </P>
<P align=center><B>AGREEMENT</B> </P>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>1.</B> </TD>
    <TD>
      <P align=justify><B>License of Technology. </B>Subject to the terms and 
      conditions of this Agreement, LICENSOR hereby grants to LICENSEE an 
      exclusive and/or semi-exclusive (depending on the type of Product Line), 
      non-transferable, non-sub-licensable license, for the <B>Technology </B>to 
      develop, test, make, sell, offer for sale and distribute the End Products 
      consisting of the Product Lines as identified in <U>Exhibit B </U>during 
      the Term of this Agreement. LICENSOR has the right to 
  update<U> Exhibit A</U> as necessary in relation to the listed patent 
applications as may be required by the patent and trademark offices during the 
course of prosecution. </P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_3></A>

<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify><B>Non-transferable: </B>The license granted by this 
      Section 1 may not be transferred or sublicensed by LICENSEE without 
      LICENSOR&#146;s written consent. However, LICENSEE has the right to name one 
      (1) individual sublicense partner in each Territory (&#147;<B>Partner</B>&#148;) to 
      facilitate its rights and obligations under this Agreement. LICENSEE shall 
      designate in writing to LICENSOR the Partner for LICENSOR&#146;s confirmation, 
      which shall not be unreasonably withheld or delayed. Provided, however, 
      that the Partner agrees in writing to all obligations of LICENSEE 
      hereunder, including those relating to confidentiality and non-use 
      regarding both Parties&#146; Confidential Information. In the event that 
      LICENSEE performs one or more of its obligations under this Agreement 
      through any such Partner, then LICENSEE shall at all times be responsible 
      for the performance by such Partner of LICENSEE&#146;s obligations hereunder, 
      including, but not limited to, LICENSEE&#146;S obligations under Sections 11, 
      12 and 13.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify><B>Product Lines: </B>The Parties agree to the meaning of 
      &#147;Product Lines&#148; based on the following list of examples: all products that 
      are generally recognized as<font style="text-indent:5%"> ******* </font> shall constitute one product line (the <font style="text-indent:5%"> ******* </font>all 
      other<font style="text-indent:5%"> ******* </font> constitute one product line (the &#147;<font style="text-indent:5%"> ******* </font>&#148;); and all constitute one product 
      line (the &#147;<font style="text-indent:5%">*******</font>&#148;). The Parties agree that LICENSEE is not limited to 
      production of the End Products as identified in <U>Schedule B </U>to this 
      Agreement, but that LICENSEE may create, test, produce, and sell 
      additional new End Products on a non-exclusive basis that are derived from 
      or otherwise incorporate the Technology and such new End Products must 
      always contain some<font style="text-indent:5%"> ******* </font> with the caveat that all such additional End Products 
      are only to be distributed and/or sold to Permitted Locations as defined 
      in Section 1. Such new End Products are subject to Section 3(b) 
  below.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>c)</B> </TD>
    <TD>
      <P align=justify><B>Active Substances: </B>Nothing in this Agreement 
      infers applicability of the Technology by LICENSEE for enabling active 
      substance incorporation and potentiation in LICENSEE&#146;s End Products, other 
      than derived from marijuana with or without hemp. LICENSEE is prohibited 
      from developing, manufacturing or selling, whether directly or indirectly, 
      including through its Partner, in each Territory, any Product Lines that 
      are marketed as the following types of products: (i) a fat soluble vitamin 
      product for vitamins A, D, E, and/or K, whether in their natural or 
      synthetic forms; (ii) a Non-Steroidal Anti Inflammatory (NSAID) product 
      including, but not limited to, acetaminophen, ibuprofen, acetylsalicylic 
      acid, diclofenac, indomethacin, and piroxicam; or (iii) a nicotine 
      product. LICENSEE is permitted to incorporate other active substances 
      within their Product Lines and the Parties agree that the End Products as 
      defined will always<font style="text-indent:5%"> ******* </font> and shall only be distributed and/or sold in the 
      Permitted Locations; and the Parties further agree that any such End 
      Products that incorporate active substances beyond those derived from 
      marijuana and/or hemp shall still fall under one of the Product Line 
      classifications as defined in Section 1 with all associated obligations by 
      the LICENSEE; and the Parties further agree there is no requirement to pay 
      more than one set of fees as described in Exhibit C regardless of whether 
      more than a single active substance is utilized in any given 
  product.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>2)</B> </TD>
    <TD>
      <P align=justify><B>Exclusivity and Semi-exclusivity Licenses and License 
      Option. </B>LICENSEE will have the following rights to produce and sell 
      the End Products in the state of Colorado excluding any native lands 
      therein (<B>&#147;Territory&#148;</B>) using the Technology licensed pursuant to 
      this Agreement.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_4></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD colSpan=2>
  <P align=justify><B><U><font style="text-indent:5%"> ******* </font>Product Line:</U></B></P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%" colspan="2"><font style="text-indent:5%"> ************************************************************************************</font></TD>
    </TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD colSpan=2>
      <P align=justify><B><U>Other Product Lines: </U></B>LICENSEE will also 
      have Semi-exclusive rights, as defined above in Section 2(a)(ii), for the 
      term of this Agreement as per Section 4 to launch the other Product Lines 
      within the Territory.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>c)</B> </TD>
    <TD colSpan=2 width="90%">
      <P align=justify><B><U>License Option: </U></B>Furthermore, until<font style="text-indent:5%"> ******* </font> LICENSOR 
      will reserve one license in each of these three named states &#150; Washington, 
      Oregon, and California excluding any native lands therein &#150; for the 
      benefit of LICENSEE (&#147;<B>License Option</B>&#148;), to be<font style="text-indent:5%"> ******* </font> and Non-exclusive in 
      the case of the other Product Lines, to distribute and/or sell End 
      Products into Permitted Locations as defined above. If and only at such 
      time as LICENSEE sells or causes to sell directly or through its Partner, 
      as described in Section 1(a) (&#147;<B>Exercise of License Option</B>&#148;), any 
      End Products utilizing the Technology in any or all of these additional 
      states, then LICENSEE does hereby agree to a license of the Technology for 
      each state into which it has exercised the License Option that is 
      identical to this Agreement, including that LICENSEE agrees to the 
      identical fee structure and payment terms, for each individual state, as 
      agreed to in this Agreement (&#147;<B>Subsequent License Agreement</B>&#148;). Each 
      Subsequent License Agreement shall have a term of two (2) years from the 
      date of signing the Subsequent Agreement, except in California where the 
      two (2) year term of the Subsequent License Agreement in that state shall 
      begin at a later date than the effective date of License Option in that 
      state, <font style="text-indent:5%"> ******* </font>All such Subsequent License Agreements shall follow the same terms 
      of this Agreement except with respect to the exclusivity benefits as 
      described above. Subsequent License Agreements shall be considered 
      &#147;entered into by the parties&#148; and effective by both parties executing a 
      written addendum to this Agreement acknowledging that the parties have 
  entered into any such Subsequent License Agreement.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>d)</B> </TD>
    <TD colSpan=2>
      <P align=justify><B><U>LICENSOR&#146;s Products: </U></B>LICENSOR shall not be 
      prohibited from (i) licensing or similar arrangements with respect to the 
      Technology outside of the Territory, subject to the License Option set 
      forth above; or (ii) licensing its Technology on the semi-exclusive basis 
      provided for herein, at all times and in all locations, subject to the 
      terms of this Agreement, including the exclusivity provisions and License 
      Options. LICENSOR is expressly permitted to license its Technology on any 
      basis it chooses, at any time, for producing and commercializing its own 
      products, provided, however, that LICENSOR would be considered as one of 
      the three (3) permitted licensees in any of the territories where LICENSEE 
      retains semi-exclusive rights.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>e)</B> </TD>
    <TD colSpan=2>
      <P align=justify><B><U>Severance Fee: </U></B>LICENSEE may elect to end 
      sales of a Product Line at its sole discretion with a severance fee 
      (&#147;<B>Severance Fee&#148;) </B>set forth in <U>Exhibit C. </U>If LICENSEE elects 
      to end sales of any Product Line, then any other licensing provision 
      benefits with respect to that Product Line also end at that 
  time.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>3)</B> </TD>
    <TD>
      <P align=justify><B>Rights and Obligations Related to the Technology. 
      </B>Except as expressly provided in this section or elsewhere in this 
      Agreement, neither Party will be deemed by this Agreement to have been 
      granted any license or other rights to the other Party&#146;s products, 
information or other intellectual property rights, either expressly or by 
implication, estoppel or otherwise. <b></b></P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_5></A><B>

<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify><B><U>LICENSOR Intellectual Property: </U></B>LICENSOR 
      retains full, absolute, and complete rights to all processes covered or 
      described in all of its patent applications filed prior to the date of 
      this Agreement, and any future continuations, continuations in part or 
      divisional applications filed thereto, including but not limited to the US 
      Provisional patent applications, US Utility patent application, and the 
      International patent application, that comprise the Technology 
      (&#147;<B>Licensor IP</B>&#148;), unless LICENSOR allows these applications to 
      abandon or lapse, or otherwise fails to protect the Technology . Except as 
      expressly provided for in Section 2, nothing in this Agreement or in the 
      conduct of the Parties shall be interpreted as preventing LICENSOR from 
      granting to any other person a license for use of the Technology or from 
      using the Technology in any manner whatsoever.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify><B><U>LICENSEE Intellectual Property</U></B>: Any 
      intellectual property resulting from LICENSEE&#146;s work, know-how, or 
      development that does not include or rely upon the Technology, Licensor IP 
      or jointly owned intellectual property, as described in this Agreement, 
      shall be owned by LICENSEE (&#147;<B>Licensee IP</B>&#148;).</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>c)</B> </TD>
    <TD>
      <P align=justify><B><U>Improvements</U></B>:</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="15%"  >&nbsp;</TD>
    <TD vAlign=top width="5%">i) </TD>
    <TD>
      <P align=justify>LICENSOR Improvements: The entire right and title to the 
      Technology, whether or not patentable, and any patent applications or 
      patents based thereon, which directly relate to and are not severable from 
      LICENSOR IP and which are improvements thereto by LICENSOR, its employees 
      or others acting solely on LICENSOR&#146;s behalf shall be owned solely by 
  LICENSOR (&#147;Licensor Improvements&#148;).<font style="text-indent:5%"> ******* </font></P></TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD vAlign=top width="5%">iv) </TD>
    <TD>
      <P align=justify><U>Improvements; Assignment. </U>LICENSEE and LICENSOR 
      hereby represent that all Partners, employees and other persons acting on 
      its behalf in performing its obligations under this Agreement shall be 
      obligated under a binding written agreement to assign, or as it shall 
      direct, all Joint Improvements that include or rely on the Technology 
      conceived or reduced to practice by such Partners, employees or other persons 
      acting on its behalf in accordance with this Agreement to the benefit of 
  LICENSOR and LICENSEE.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_6></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD vAlign=top width="5%">v) </TD>
    <TD>
      <P align=justify><U>Improvements; Confidential Information</U>. All 
      Improvements shall constitute Confidential Information and shall be 
      subject to the confidentiality provisions set forth in this 
    Agreement.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>d)</B> </TD>
    <TD>
      <P align=justify><B><U>Inventions; 
Reporting</U></B>:</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="15%"  >&nbsp;</TD>
    <TD vAlign=top width="5%">i) </TD>
    <TD>
      <P align=justify>Upon making any invention that does NOT include or rely 
      upon the Technology LICENSEE has no obligation to share such information 
      of invention with LICENSOR nor inform LICENSOR of said invention, and 
      LICENSEE retains unrestricted rights and ability to use, assign, license, 
      seek patent and other forms of intellectual property protection related to 
      said invention. For the avoidance of doubt, any such new invention, 
      development, technology, and/or intellectual property belongs solely to 
      LICENSEE. Upon making any invention that does or does NOT include or rely 
      upon the Technology, LICENSOR has no obligation to share such information 
      of invention with LICENSEE nor inform LICENSEE of said invention, and 
      LICENSOR retains unrestricted rights and ability to use, assign, license, 
      seek patent and other forms of intellectual property protection related to 
      said invention.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>e)</B> </TD>
    <TD colSpan=2>
      <P align=justify><B><U>Jointly Owned Intellectual Property</U></B>: If any 
      patent applications are filed seeking to protect any Joint Improvements 
      (&#147;<B>Jointly Owned IP</B>&#148;), each Party shall be named as joint 
  inventors.<font style="text-indent:5%"> ******* </font></P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>f)</B> </TD>
    <TD colSpan=2>
      <P align=justify><B><U>No Challenge</U></B><B>. </B>LICENSEE expressly 
      acknowledges and agrees that all rights in and to the Technology shall 
      remain vested in LICENSOR, and LICENSEE shall not assert any rights to the 
      Technology except as otherwise provided in this Section 3.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>g)</B> </TD>
    <TD colSpan=2>
      <P align=justify><B><U>Notice Requirements</U></B><B>. </B>To the extent 
      required by applicable rules and regulations, including those of the MED 
      related to packaging, LICENSEE agrees that it will include such patent 
      notices and other proprietary notices on all End Products or related 
      materials that contain any Technology as may be reasonably required by MED 
      or other regulators in order to give appropriate notice of all 
      intellectual property rights therein or pertaining thereto.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>h)</B> </TD>
    <TD colSpan=2>
      <P align=justify><B><U>Quality 
Control</U></B><B>.</B></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="15%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>i)</B> </TD>
    <TD>
      <P align=justify>LICENSEE agrees to maintain and preserve the quality of 
      the Technology, and to use the Technology in good faith and in a manner 
      consistent with the uses approved herein.</P></TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>ii)</B> </TD>
    <TD>
      <P align=justify>LICENSEE shall (a) ensure that all End Products and 
      related materials under the Technology are developed, tested, promoted, 
      manufactured and distributed in a professional manner in compliance with 
      all generally accepted industry standards, and (b) comply in all material 
      respects with any and all laws, rules and regulations that are applicable 
      to the development, testing, promotion, manufacture and distribution of the End 
Products and such related materials.<b> </b></P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_7></A><BR>

<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>i)</B> </TD>
    <TD>
      <P align=justify><B><U>Prosecution and Maintenance</U></B><B>. 
      </B>LICENSOR shall be solely responsible for, and have control of, 
      preparing, filing, prosecuting, obtaining, and maintaining the Technology 
      (including Provisional Patent Applications and, if any, issued Patents). 
      LICENSOR shall take such actions as it shall deem to be appropriate in its 
      discretion in connection therewith, and shall pay all costs and expenses 
      incurred by it in connection with the foregoing activities.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>j)</B> </TD>
    <TD>
      <P align=justify><B><U>Infringement</U></B><B>. </B>If LICENSEE learns of 
      any activity by a third party that might constitute an infringement of 
      LICENSOR&#146;s rights in any of the Technology, or if any third party asserts 
      that LICENSEE&#146;s use of the Technology constitutes unauthorized use or 
      infringement, LICENSEE shall so notify LICENSOR.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>k)</B> </TD>
    <TD>
      <P align=justify><B><U>Enforcement</U></B><B>. </B>LICENSOR has the right, 
      but not the obligation, to enforce its rights against any third party 
      infringement and to defend LICENSEE&#146;s right to use the Technology. If 
      LICENSOR prosecutes any alleged infringement of the Technology, or defends 
      LICENSEE&#146;s right to use the Technology, LICENSOR shall control such 
      litigation and shall bear the expense of such actions. LICENSEE shall make 
      all reasonable efforts to assist LICENSOR therewith, including joining 
      such action as a party plaintiff or providing such evidence and expert 
      assistance as LICENSEE may have within its control, with all costs for 
      such cooperation to be borne by LICENSOR. LICENSOR shall retain the award 
      of any damages in this case. If LICENSOR chooses to not enforce against an 
      alleged infringement, LICENSEE may itself enforce LICENSOR&#146;s rights (and 
      its own rights as a Licensee) in the Technology, with all costs to be 
      borne by LICENSEE. LICENSEE shall retain the award of any damages in this 
      case.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>4)</B> </TD>
    <TD>
      <P align=justify><B>Term and Termination.</B></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify><U>Term. </U>This Agreement shall take effect upon 
      signing by both Parties, and shall remain in effect for the shorter of 
      either two (2) years; or, such circumstances as described in Section 4.c. 
      After the conclusion of the initial Term, this Agreement may be renewed, 
      by written agreement by both Parties, or renegotiated at the end of this 
      Term to reflect the then-current economic conditions of the marketplace 
      and the Parties. If LICENSOR abandons all patent applications or fails to 
      exercise its right to file an application for the provisional patents, 
      LICENSOR shall immediately notify LICENSEE. In the event of such actions 
      by LICENSOR, and where LICENSOR fails to protect the Technology through 
      some means other than a patent, LICENSEE shall retain the right to 
      immediately terminate the Agreement.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify><U>Termination. </U>This Agreement and the licenses 
      granted hereunder may be terminated prior to the expiration of the initial 
      term or any renewal term of this Agreement as 
follows:</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="15%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>i)</B> </TD>
    <TD>
      <P align=justify>This Agreement may be terminated by LICENSOR by written 
      notice to LICENSEE upon the occurrence of any of the following: (i) 
      failure of LICENSEE to pay any license fees for more than sixty (60) days 
      after they become due; (ii) LICENSEE&#146;s violation of the provisions of 
      Sections 7 and 8 or LICENSEE&#146;s material breach of any other term of this 
      Agreement, which breach is not cured within sixty (60) days after written 
      notice of such breach from LICENSOR; (iii) failure of LICENSEE to maintain 
      all required licenses and governmental authorizations required for the 
      conduct of its business or to comply in all material respects with 
      applicable state and local laws; or (iv)LICENSEE ceases operations, makes 
      a general assignment for the benefit of creditors, or is the subject of a 
      voluntary or involuntary bankruptcy, insolvency or similar 
    proceeding.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_8></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="15%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>ii)</B> </TD>
    <TD>
      <P align=justify>This Agreement may be terminated by LICENSEE by written 
      notice to LICENSOR in the event of material breach by LICENSOR of its 
      obligations or representations and warranties under this Agreement, which 
      breach is not cured within sixty (60) days after written notice of such 
      breach from LICENSEE.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>c)</B> </TD>
    <TD>
      <P align=justify>This Agreement may be terminated by LICENSEE if LICENSOR 
      allows abandonment or lapse of all pending patent applications listed in 
      <U>Exhibit A </U>or if a judgment or decree is entered in any U.S. court 
      proceeding holding any claim of any patent, upon which the licensed field 
      of use of the Technology hereunder relies, invalid or unenforceable, which 
      judgment or decree is not further reviewable by a superior 
  tribunal.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>d)</B> </TD>
    <TD>
      <P align=justify><U>Effect of Termination</U>. <font style="text-indent:5%"> ******* </font>If the Agreement expires 
      without any renewal thereof, and either LICENSOR has been granted patents 
      for the Technology or has not received a final refusal of patent 
      registration, then LICENSEE must cease and desist all utilization of the 
      Technology. In any event, upon the natural future expiration of all 
      pending and issued patents as applicable related to the Technology 
      described herein, or at any time if the patents covering the Technology 
      are finally refused by the U.S. Patent Office or if LICENSOR fails to 
      protect the Technology, the License Agreement shall expire and LICENSEE 
      shall have no further payment obligations to 
LICENSOR.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>5)</B> </TD>
    <TD>
      <P align=justify><B>Compensation and 
Payment.</B></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify>In consideration for the license granted to LICENSEE 
      under this Agreement, LICENSEE shall pay LICENSOR certain license fees set 
      forth in <U>Exhibit D </U>(collectively, the &#147;<B>License Fee</B>&#148;). The 
      License Fee for a period shall be paid by LICENSEE to LICENSOR no later 
      than the first day of each calendar month during the Term, in U.S. funds, 
      by check or wire transfer of immediately available funds pursuant to the 
      bank account identified by LICENSOR in advance of such payment.<font style="text-indent:5%"> ******* </font> expenses 
      when due will be a material breach of this Agreement by LICENSEE. If any 
      payment due to LICENSOR under this Agreement is not paid within thirty 
      (30) days following such Party&#146;s written demand therefore, then such 
      payment shall bear interest at the rate of one and one-half percent (1.5%) 
  per month from the date such payment was originally due.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
  <P align=justify><font style="text-indent:5%"> ******* </font></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>6)</B> </TD>
    <TD>
      <P align=justify><B>Obligations.</B></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify><U>Obligations of LICENSEE. </U>LICENSEE shall be solely 
      responsible for all costs of producing the End Products, including raw 
      materials and labor. LICENSEE acknowledges and agrees that it is solely 
      responsible for (i) procurement of marijuana extraction machinery, 
      marijuana, marijuana oils, hemp, hemp oils, and other raw materials; (ii) 
      compliance with all state and local laws relating to production and sale 
      of marijuana products; and (iii) procurement and maintenance 
  of all required licensing and permits and/or operating 
      authorities, including proper zoning of production and distribution 
  facilities.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_9></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify><U>Obligations of 
LICENSOR.</U></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="15%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>i)</B> </TD>
    <TD>
      <P align=justify>Upon execution of this Agreement, LICENSOR shall make the 
      Technology and any additional documents or materials not yet provided as 
      described in Section 1 otherwise necessary to effectuate the license of 
      the Technology contemplated herein available for LICENSEE.</P></TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>ii)</B> </TD>
    <TD>
      <P align=justify>LICENSOR shall provide LICENSEE with support in 
      connection with LICENSEE's use of the Technology during the term of this 
      Agreement, with reasonable travel expenses paid for by LICENSEE. Any such 
      travel expenses must be approved in advance by LICENSEE. LICENSOR shall 
      not charge any management or professional hourly or daily fee for such 
      support.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>7)</B> </TD>
    <TD>
      <P align=justify><B>Representations and 
Warranties.</B></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify><U>Representations and Warranties of LICENSEE. 
      </U>LICENSEE represents and warrants to LICENSOR as follows: (i) LICENSEE 
      is a limited liability company duly organized and in good standing under 
      the laws of the State of Delaware; (ii) the execution, delivery and 
      performance of this Agreement by LICENSEE has been duly authorized by all 
      necessary action on the part of LICENSEE&#146;s managers and/or members and 
      does not violate, conflict with, or require the consent or approval of any 
      third party pursuant to, any contract or legally binding obligation to 
      which LICENSEE is subject; (iii) this Agreement constitutes the valid and 
      binding obligation of LICENSEE enforceable against LICENSEE in accordance 
      with its terms; and (iv) LICENSEE possesses all required licenses, permits 
      or operating authorities necessary for its operations and the manufacture 
      and sale of the End Products as marijuana products and is in compliance 
      with all applicable state and local laws and regulations.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify><U>Representations and Warranties of LICENSOR. 
      </U>LICENSOR represents and warrants to LICENSEE as follows: (i) LICENSOR 
      is a corporation duly organized and in good standing under the laws of the 
      State of Nevada; (ii) the execution, delivery and performance of this 
      Agreement by LICENSOR has been duly authorized by all necessary action on 
      the part of LICENSOR&#146;s directors and officers and does not violate, 
      conflict with, or require the consent or approval of any third party 
      pursuant to, any state or local law or regulation applicable to LICENSOR 
      or any contract or legally binding obligation to which LICENSOR is 
      subject; (iii) this Agreement constitutes the valid and binding obligation 
      of LICENSOR enforceable against LICENSOR in accordance with its terms; and 
      (iv) the Technology and Licensed Patents do not infringe any third-party 
      rights.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>8)</B> </TD>
    <TD>
      <P align=justify><B>Confidentiality. </B>In addition to the 
      Confidentiality Agreement entered into by the Parties on September 8, 
      2016, at all times during the term of this Agreement (including any 
      renewal term) and thereafter, LICENSEE will not use or disclose and will 
      otherwise keep confidential any trade secrets or proprietary information, 
      including, but not limited to the Technology and other intellectual 
      property of LICENSOR (collectively, the &#147;<B>Confidential Information</B>&#148;) 
      except to the extent required to perform its obligations under this 
      Agreement. Without limitation of the foregoing, LICENSEE will hold the 
      Confidential Information in confidence and will (a) exercise the same 
      degree of care, but no less than a reasonable degree of care, to prevent 
      its disclosure as LICENSEE would take to safeguard its own confidential or 
      proprietary information, and (b) limit disclosure of Confidential 
      Information, including any notes, extracts, analyses or materials that 
      would disclose Confidential Information, solely to those of its employees 
      who need to know the information for purposes 
of performing its obligations under this Agreement and who agree 
to keep such information confidential. Upon termination of this Agreement, 
LICENSEE shall immediately return all Confidential Information to LICENSOR and 
LICENSOR shall have the right to conduct an on-site audit of the LICENSEE within 
three (3) business days of termination to ensure compliance with the terms of 
this Agreement, at LICENSOR&#146;S expense.<b> </b></P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_10></A><BR>

<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify><U>Limitations. </U>This section does not apply to any 
      information that: (a) is already lawfully in the receiving Party's 
      possession (unless received pursuant to a nondisclosure agreement); (b) is 
      or becomes generally available to the public through no fault of the 
      receiving Party; (c) is disclosed to the receiving Party by a third party 
      who may transfer or disclose such information without restriction; (d) is 
      required to be disclosed by the receiving Party as a matter of law 
      (provided that the receiving Party will use all reasonable efforts to 
      provide the disclosing Party with prior notice of such disclosure and to 
      obtain a protective order therefor, with all costs to be borne by the 
      disclosing Party); (e) is disclosed by the receiving Party with the 
      disclosing Party's approval; or (f) is independently developed by the 
      receiving Party without any use of confidential information. In all cases, 
      the receiving Party will use all reasonable efforts to give the disclosing 
      Party ten (10) days' prior written notice of any disclosure of information 
      under this Agreement. The Parties will maintain the confidentiality of all 
      confidential and proprietary information learned pursuant to this 
      Agreement for a period of ten (10) years from the date of termination of 
      this Agreement.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify><U>Saving Provision</U>. The Parties agree and stipulate 
      that the agreements contained in this Section are fair and reasonable in 
      light of all of the facts and circumstances of their relationship; 
      however, the Parties are aware that in certain circumstances courts have 
      refused to enforce certain agreements. Therefore, in furtherance of and 
      not in derogation of the provisions of the preceding paragraph the parties 
      agree that in the event a court should decline to enforce the provisions 
      of the preceding paragraph, that paragraph shall be deemed to be modified 
      to restrict non-enforcing Party&#146;s rights under this Agreement to the 
      maximum extent, in both time and geography, which the court shall find 
      enforceable.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>9)</B> </TD>
    <TD>
      <P align=justify><B>Injunctive Relief. </B>The Parties agree that any 
      breach of this Agreement by LICENSEE shall cause LICENSOR immeasurable and 
      irreparable harm and LICENSOR shall be entitled to seek immediate 
      injunctive relief from any court of competent jurisdiction, in addition to 
      any other remedies that LICENSOR may have at law or in equity.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>10)</B> </TD>
    <TD>
      <P align=justify><B>Indemnification.</B></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify>LICENSEE agrees to indemnify LICENSOR and hold LICENSOR 
      harmless from and against any and all liabilities, losses and expenses 
      arising from (i) LICENSEE&#146;s unauthorized use of the Technology; (ii) 
      LICENSEE&#146;s failure to comply with applicable laws or to maintain all 
      required licenses and governmental authorizations; (iii) any breach of 
      LICENSEE&#146;s representations and warranties set forth herein; and (iv) any 
      liability to third parties as a result of LICENSEE&#146;s production, 
      distribution and/or sale of End Products, except as to any liability 
      arising out of the proper use of the Technology.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify>LICENSOR agrees to indemnify LICENSEE and hold LICENSEE 
      harmless from and against any and all liabilities, losses and expenses 
      arising from (i) any breach of LICENSOR&#146;s representations and warranties 
      set forth herein; and (ii) any claims of infringement raised by third 
      parties as to the Technology or Licensed 
Patents.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>11)</B> </TD>
    <TD>
      <P align=justify><B>Limitation of Liability. </B>EXCEPT TO THE EXTENT 
      OTHERWISE EXPRESSLY AGREED TO IN THIS AGREEMENT, NEITHER PARTY SHALL BE 
      LIABLE TO THE OTHER PARTY FOR LOST PROFITS OR FOR ANY DIRECT, INDIRECT, INCIDENTAL, 
      CONSEQUENTIAL, SPECIAL, PUNITIVE OR EXEMPLARY DAMAGES IN CONNECTION WITH 
      THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, HOWEVER 
      CAUSED, UNDER ANY THEORY OF LIABILITY. THE FOREGOING SHALL NOT LIMIT 
      LICENSEE&#146;S LIABILITY FOR UNAUTHORIZED USE BY LICENSEE OF LICENSOR&#146;S 
  TECHNOLOGY.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_11></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%" ></TD>
    <TD vAlign=top width="5%"><B>12)</B> </TD>
    <TD>
      <P align=justify><B>No Warranties. OTHER THAN THE EXPRESS WARRANTIES 
      PROVIDED HEREIN, </B>LICENSOR MAKES NO EXPRESS WARRANTIES OF 
      MERCHANTABILITY OR FITNESS OR EFFICACY FOR A PARTICULAR PURPOSE OF THE 
      TECHNOLOGY AND/OR ANY END PRODUCTS PRODUCED FROM SAID TECHNOLOGY AND SHALL 
      NOT BE HELD LIABLE FOR PROFITABILITY OF TECHNOLOGY AND/OR END PRODUCTS OR 
      HELD LIABLE UNDER ANY OTHER THEORY OF LIABILITY.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>13)</B> </TD>
    <TD>
      <P align=justify><B>Insurance. </B>For the period of time required to 
      cover its obligations hereunder, each Party will maintain third party 
      provided insurance in types and amounts customary for the type of business 
      it conducts, and in any event reasonably adequate to cover any liabilities 
      arising out of its obligations hereunder<B>. </B>Further, LICENSEE will 
      maintain product liability insurance reasonably adequate to cover any 
      liabilities arising out of the sale and distribution of End Products. Upon 
      a Party&#146;s request, the other Party will provide to the requesting Party a 
      certificate of insurance showing that such insurance is in place, which 
      certificate shall demonstrate the amounts, exclusions and deductibles of 
      such insurance coverage. Each Party shall notify the other Party in 
      writing no less than thirty (30) days prior to the cancellation, 
      termination or modification of the insurance coverage(s) described in the 
      notifying Party&#146;s insurance certificate(s). Nothing in this Section shall 
      in any way be construed to limit the liability of a Party under this 
      Agreement.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>14)</B> </TD>
    <TD>
      <P align=justify><B>Compliance with Laws. </B>In connection with this 
      Agreement, LICENSEE agrees to comply with all applicable laws, statutes 
      and ordinances of any governmental authority, including, but not limited 
      to, the MED and the City of<font style="text-indent:5%"> ******* </font>, that may be applicable to LICENSEE, its 
  activities under this Agreement or the End Products.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>15)</B> </TD>
    <TD>
      <P align=justify><B>Conformance with Regulations. </B>The Parties 
      acknowledge and agree that this Agreement, and the licensing of the 
      Technology, is neither intended to convey any ownership interest in 
      LICENSEE to LICENSOR nor grant LICENSOR any control over LICENSEE. In the 
      event that the MED indicates otherwise with regards to this Agreement or 
      any portion thereof, then the Parties shall promptly negotiate in good 
      faith for a period of forty-five (45) days to modify this Agreement in 
      order to conform with any guidance proffered by the MED. In the event the 
      Parties cannot reach an agreement within forty-five (45) days&#146; notice by 
      the MED or the City that this Agreement must be reformed, this Agreement 
      shall terminate pursuant to Section 5 above, and the Parties shall 
      thereafter have no further obligation to each other hereunder.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>16)</B> </TD>
    <TD>
      <P align=justify><B>Employees; Agents; Representatives. </B>Employees, 
      agents and/or representatives, if any, of either Party, including 
      LICENSEE&#146;s Partner, who perform services for either Party pursuant to this 
      Agreement shall also be bound by the provisions of this 
  Agreement.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>17)</B> </TD>
    <TD>
      <P align=justify><B>Relationship of Parties. </B>The legal relationship of 
      the Parties is exclusively that of licensor and licensee and no 
      employer-employee, principal-agent, partnership, franchise, agency, joint 
      venture or other legal relationship is created by this Agreement. Neither 
      Party shall have the authority to enter into any contracts on behalf of 
      the other Party.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_12></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>18)</B> </TD>
    <TD>
      <P align=justify><B>Successors; Assignment; Binding Agreement. </B>Except 
      as otherwise provided in this Agreement, LICENSEE may not assign or 
      transfer its rights or delegate its obligations under this Agreement 
      without LICENSOR&#146;S prior written consent. LICENSOR may freely assign this 
      Agreement or any rights under this Agreement, or delegate any duties under 
      this Agreement without LICENSEE&#146;s consent. This Agreement inures to the 
      benefit of, and shall be binding upon, the successors and assigns of the 
      parties to this Agreement. This Agreement and all of its provisions and 
      conditions are for the sole and exclusive benefit of the Parties and their 
      respective successors and permitted assigns.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>19)</B> </TD>
    <TD>
      <P align=justify><B>Modifications and Waivers. </B>This Agreement may be 
      amended only by a written agreement signed by both Parties. With regard to 
      any power, remedy or right provided in this Agreement, no waiver or 
      extension of time shall be effective unless expressly contained in a 
      writing signed by the waiving Party, no alteration, modification or 
      impairment shall be implied by reason of any previous waiver, extension of 
      time, delay or omission in exercise or other indulgence, and waiver by any 
      Party of the time for performance of any act or condition hereunder does 
      not constitute a waiver of the act or condition itself.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>20)</B> </TD>
    <TD>
      <P align=justify><B>Notice. </B>Except as otherwise provided in this 
      Agreement, notices required to be given pursuant to this Agreement shall 
      be effective when received, and shall be sufficient if given in writing, 
      hand- delivered, sent by facsimile with confirmation of receipt, sent by 
      First Class Mail, return receipt requested (for all types of 
      correspondence), postage prepaid, or sent by overnight courier service and 
      addressed as set forth below, or as amended by either Party, respectively, 
      from time to time:</P></TD></TR></TABLE><BR>
<P style="MARGIN-LEFT: 15%" align=justify><font style="text-indent:5%"> ******* </font><br>
    <font style="text-indent:5%"> ******* </font><br>
      <font style="text-indent:5%"> ******* </font><br>
        <font style="text-indent:5%"> ******* </font><br>
          <font style="text-indent:5%"> ******* </font><br>
  <br>
  If to LICENSOR: <BR>
  Lexaria Bioscience 
Corp.<BR>950, 1130 W. Pender Street <BR>Vancouver, British Columbia <BR>V6E 4A4 
<BR>Canada <BR>Attn: Chris Bunka </P>
<P style="MARGIN-LEFT: 15%" align=justify>No objection may be made to the manner 
of delivery of any notice or other communication in writing actually received by 
a Party. </P>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>21)</B> </TD>
    <TD>
      <P align=justify><B>Entire Agreement. </B>This Agreement, including the 
      attached exhibits, constitutes the entire agreement of the Parties hereto 
      relating to the subject matter hereof and there are no written or oral 
      terms or representations made by either Party other than those contained 
      herein.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>22)</B> </TD>
    <TD>
      <P align=justify><B>Publicity. </B>Without the prior written consent of 
      the other Party, neither Party shall disclose the terms and conditions of 
      this Agreement, except disclosure may be made as is reasonably necessary 
      to the disclosing Party's bankers, attorneys, or accountants or except as 
      may be required by law. The Parties understand and agree that LICENSOR may 
      be compelled by Federal or State regulators to publicly disclose the 
      signing of said License Agreement naming both Parties. If LICENSOR is 
      compelled by Federal or State regulators to publicly disclose the signing 
      of said License Agreement, LICENSOR will share its planned announcement 
      with LICENSEE beforehand for LICENSEE&#146;s review and approval, not to be 
      unreasonably withheld or delayed, and it will also ensure that no 
      compromise of the LICENSEE&#146;s existing secret processes or intellectual 
      property, nor of LICENSEE`S personal or private information occurs through 
  this announcement.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_13></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>23)</B> </TD>
    <TD>
      <P align=justify><B>Expenses. </B>Each Party to this Agreement shall bear 
      all of its own expenses in connection with the execution, delivery and 
      performance of this Agreement and the transactions contemplated hereby, 
      including without limitation all fees and expenses of its agents, 
      representatives, counsel and accountants.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>24)</B> </TD>
    <TD>
      <P align=justify><B>Governing Law; Jurisdiction. </B>The validity, 
      interpretation, construction, performance and enforcement of this 
      Agreement shall be governed by the laws of the State of Colorado, 
      regardless of the choice of law provisions of Colorado or any other 
      jurisdiction.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>25)</B> </TD>
    <TD>
      <P align=justify><B>Dispute Resolution.</B></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>a)</B> </TD>
    <TD>
      <P align=justify><U>Mandatory Procedures</U>. The Parties agree that any 
      dispute arising out of or relating to this Agreement shall be resolved 
      solely by means of the procedures set forth in this Section and that such 
      procedures constitute legally binding obligations that are an essential 
      provision of this Agreement. If either Party fails to observe the 
      procedures of this Section, as may be modified by their written agreement, 
      the other Party may bring an action for specific performance of these 
      procedures in any court in the State of Colorado.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>b)</B> </TD>
    <TD>
      <P align=justify><U>Equitable Remedies</U>. Although the procedures 
      specified in this Section are the sole and exclusive procedures for the 
      resolution of disputes arising out of or relating to this Agreement, 
      either Party may seek a preliminary injunction or other provisional 
      equitable relief if, in its reasonable judgment, such action is necessary 
      to avoid irreparable harm to itself or to preserve its rights under this 
      Agreement.</P></TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>c)</B> </TD>
    <TD>
      <P align=justify><U>Dispute Resolution 
Procedures</U>.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="15%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>i)</B> </TD>
    <TD>
      <P align=justify><U>Mediation</U>. In the event any dispute arising out of 
      or relating to this Agreement remains unresolved within sixty (60) days 
      from the date the affected party informed the other party of such dispute, 
      either party may initiate mediation upon written notice to the other party 
      (&#147;Notice Date&#148;), whereupon both parties shall be obligated to engage in a 
      mediation proceeding under the then current Center for Public Resources 
      (&#147;CPR&#148;) Model Procedure for Mediation of Business Disputes 
      (www.cpradr.org), except that specific provisions of this Article shall 
      override inconsistent provisions of the CPR Model Procedure. The mediator 
      will be selected from the CPR Panels of Neutrals. If the parties cannot 
      agree upon the selection of a mediator within fifteen (15) business days 
      after the Notice Date, then upon the request of either party, the CPR 
      shall appoint the mediator. The parties shall attempt to resolve the 
      dispute through mediation until the first of the following occurs: (i) the 
      parties reach a written settlement, (ii) the mediator notifies the parties 
      in writing that they have reached an impasse, (iii) the parties agree in 
      writing that they have reached an impasse, or (iv) the parties have not 
      reached a settlement within sixty (60) days after the Notice 
  Date.</P></TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="15%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>ii)</B> </TD>
    <TD>
      <P align=justify>If the Parties fail to resolve the dispute through 
      mediation, or if neither Party elects to initiate mediation, each Party 
      shall have the right to pursue any other remedies legally available to 
      resolve the dispute.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>d)</B> </TD>
    <TD>
      <P align=justify><U>Performance to Continue</U>. Each Party shall continue 
      to perform its undisputed obligations under this Agreement pending final 
      resolution of any dispute arising out of or relating to this Agreement; 
      provided, however, that a Party may suspend performance of its undisputed 
      obligations during any period in which the other Party fails or refuses to 
      perform its undisputed obligations. Nothing in this Section is intended to 
      relieve LICENSEE from its obligation to make undisputed payments pursuant 
  to Section 5 of this Agreement.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_14></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>e)</B> </TD>
    <TD>
      <P align=justify><U>Statute of Limitations</U>. The Parties agree that all 
      applicable statutes of limitation and time-based defenses (such as 
      estoppel and laches) shall be tolled while the procedures set forth in 
      this Section are pending. The Parties shall cooperate in taking any 
      actions necessary to achieve this result.</P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>26)</B> </TD>
    <TD>
      <P align=justify><B>Attorneys&#146; Fees. </B>In the event of any dispute 
      between the parties arising out of this Agreement, the prevailing Party 
      shall be entitled, in addition to any other rights and remedies it may 
      have, to recover its reasonable attorneys&#146; fees and costs.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>27)</B> </TD>
    <TD>
      <P align=justify><B>No Interpretation Against Drafter. </B>Each Party 
      participated in the negotiation and drafting of this Agreement, assisted 
      by such legal and tax counsel as it desired, and contributed to its 
      revisions. Any ambiguities with respect to any provision of this Agreement 
      will be construed fairly as to all Parties and not in favor of or against 
      any Party. All pronouns and any variation thereof will be construed to 
      refer to such gender and number as the identity of the subject may 
      require. The terms &#147;include&#148; and &#147;including&#148; indicate examples of a 
      predicate word or clause and not a limitation on that word or 
    clause.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>28)</B> </TD>
    <TD>
      <P align=justify><B>Headings. </B>The headings of Sections are provided 
      for convenience only and will not affect the construction or 
      interpretation of this Agreement.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>29)</B> </TD>
    <TD>
      <P align=justify><B>Force Majeure. </B>Neither Party shall be liable for 
      any delay or failure to perform its obligations in this Agreement if such 
      delay or failure to perform is due to any cause or condition reasonably 
      beyond that Party&#146;s control, including, but not limited to, acts of God, 
      war, government intervention, riot, embargoes, acts of civil or military 
      authorities, earthquakes, fire, flood, accident, strikes, inability to 
      secure transportation, facilities, fuel, energy, labor or 
  materials.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>30)</B> </TD>
    <TD>
      <P align=justify><B>Survival. </B>In addition to LICENSEE&#146;s obligation to 
      pay LICENSOR all amounts due hereunder, the Parties obligations under this 
      Agreement shall survive expiration or termination of the Agreement only as 
      expressly provided herein</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>31)</B> </TD>
    <TD>
      <P align=justify><B>Invalidity. </B>The invalidity or unenforceability of 
      any term or terms of this Agreement shall not invalidate, make 
      unenforceable or otherwise affect any other term of this Agreement which 
      shall remain in full force and effect.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>32)</B> </TD>
    <TD>
      <P align=justify><B>Severability. </B>If any terms or provisions of this 
      Agreement shall be found to be illegal or unenforceable, notwithstanding, 
      this Agreement shall remain in full force and effect and such terms or 
      provisions shall be deemed stricken.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>33)</B> </TD>
    <TD>
      <P align=justify><B>Further Assurances. </B>Upon a Party&#146;s reasonable 
      request, the other Party shall, at requester&#146;s sole cost and expense, 
      execute and deliver all further documents and instruments, and take all 
      further acts, as are reasonably necessary to give full effect to this 
      Agreement.</P></TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%"><B>34)</B> </TD>
    <TD>
      <P align=justify><B>Counterparts. </B>The Parties may execute this 
      Agreement in multiple counterparts, each of which will constitute an 
      original and all of which, when taken together, will constitute one and 
      the same agreement.</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_15></A>
<P align=justify style="text-indent:5%">NOW, THEREFORE, in consideration of the premises and the mutual 
promises and conditions hereinafter set forth, and other good and valuable 
consideration, the receipt and sufficiency of which are hereby acknowledged, the 
Parties, intending to be legally bound, do hereby agree as follows: </P>
<P align=justify style="text-indent:5%"><B>IN WITNESS WHEREOF</B>, the parties have executed this 
Agreement intending to be legally bound as of the date set forth above. </P>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0>
  
  <TR vAlign=top>
    <TD align=left><B>&#147;LICENSOR&#148;</B> </TD>
    <TD align=left width="50%"><B>&#147;LICENSEE&#148;</B> </TD></TR>
  <TR vAlign=top>
    <TD align=left><B>LEXARIA BIOSCIENCE CORP.</B> </TD>
    <TD align=left width="50%"><font style="text-indent:5%"> ******* </font></TD>
  </TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0>
  
  <TR vAlign=top>
    <TD align=left>By:&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left 
    width="40%">&nbsp;</TD>
    <TD align=left width="10%">&nbsp;</TD>
    <TD align=left width="5%">By:&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left 
    width="39%">&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left>&nbsp;</TD>
    <TD align=left width="40%">John Docherty, President </TD>
    <TD align=left width="10%">&nbsp;</TD>
    <TD align=left width="5%">&nbsp;</TD>
    <TD align=left width="39%"><font style="text-indent:5%"> ******* </font> CEO </TD>
  </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD width="40%">&nbsp; </TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="39%">&nbsp; </TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD width="40%">&nbsp; </TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="39%">&nbsp; </TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD width="40%">&nbsp; </TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="39%">&nbsp; </TD></TR>
  <TR vAlign=top>
    <TD align=left>By:&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left width="40%"></TD>
    <TD align=left width="10%">&nbsp;</TD>
    <TD align=left width="5%">&nbsp;</TD>
    <TD align=left width="39%">&nbsp; </TD></TR>
  <TR vAlign=top>
    <TD align=left>&nbsp;</TD>
    <TD align=left width="40%">Chris Bunka, CEO </TD>
    <TD align=left width="10%">&nbsp;</TD>
    <TD align=left width="5%">&nbsp;</TD>
    <TD align=left width="39%">&nbsp; </TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_16></A><BR>
<P align=center><B><U>EXHIBIT A</U></B> </P>
<P align=center><B>TECHNOLOGY </B></P>
<P align=justify>The Technology consists of (1) the following five (5) U.S. 
Provisional Patent Applications and one (1) PCT International Patent 
Application; and (2) all technical know-how and trade secrets in regard to such 
named patents, including the use, manufacture or formulation thereof, that is 
owned or controlled by LICENSOR as of the Effective Date of this Agreement, as 
well as any future continuations, continuations in part or divisional 
applications filed pursuant to the five U.S. and one International Patent 
Applications. (the &#147;<B>Licensed Patents</B>&#148;): </P>
<P align=justify>U.S. Provisional Patent Application No. 62/010,601, filed June 
11, 2014. </P>
<P align=justify>U.S. Provisional Patent Application No. 62/037,706, filed 
August 15, 2014. </P>
<P align=justify>U.S. Provisional Patent Application No. 62/153,835, filed April 
28, 2015. </P>
<P align=justify>U.S. Provisional Patent Application No. 62/161,324, filed May 
14, 2015. </P>
<P align=justify>U.S. Utility Patent Application No. 14/735,844, filed June 10, 
2015. </P>
<P align=justify>PCT International Patent Application No. PCT/US15/35128, filed 
June 10, 2015. </P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_17></A>
<P align=center><B><U>EXHIBIT B</U></B> </P>
<P align=center><B>END PRODUCTS</B> </P>
<DIV>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
borderColor=#000000 cellSpacing=0 cellPadding=3 width="100%" border=1>
  
  <TR vAlign=top>
    <TD noWrap align=left><B>Product Line Name</B> </TD>
    <TD noWrap align=left width="50%"><B>Product Line Description</B> </TD></TR>
  <TR vAlign=top>
    <TD align=left><font style="text-indent:5%"> ******* </font></TD>
    <TD align=left width="50%"><font style="text-indent:5%"> ******* </font></TD>
  </TR>
  <TR vAlign=top>
    <TD align=left><font style="text-indent:5%"> ******* </font></TD>
    <TD align=left width="50%"><font style="text-indent:5%"> ******* </font></TD>
  </TR>
  <TR vAlign=top>
    <TD align=left><font style="text-indent:5%"> ******* </font></TD>
    <TD align=left width="50%"><font style="text-indent:5%"> ******* </font></TD>
  </TR></TABLE></DIV><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_18></A>
<P align=center><B><U>EXHIBIT C</U></B> </P>
<P align=center><B>LICENSE FEE</B> </P>
<P align=justify>Upon execution of this Agreement, LICENSEE shall pay to 
LICENSOR the License Fee as set forth below. The License Fee shall be paid in 
accordance with Section 5 of this Agreement. </P>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%" >&nbsp;</TD>
    <TD vAlign=top width="5%">(a) </TD>
    <TD colSpan=2>
      <P align=justify><B><U>Territory License Fee. </U></B>LICENSEE agrees to 
      pay to LICENSOR a signing and exclusivity and/or semi-exclusivity 
      (depending on the Product Lines implemented) license fee of<font style="text-indent:5%"> ******* </font> (&#147;<B>Territory 
      License Fee</B>&#148;). The Territory License Fee shall be paid as follows:<font style="text-indent:5%"> ******* </font> If 
      LICENSEE exercises a License Option pursuant to Section 2c for additional 
      territories, LICENSEE agrees to pay a Territory License Fee for each 
  additional territory.</P></TD></TR>
  <TR>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%">&nbsp;</TD>
    <TD vAlign=top width="5%">(b) </TD>
    <TD colSpan=2>
      <P align=justify><B><U>Usage License Fee. </U></B>For each Product Line in 
      the Territory, only for the period of time a Product Line is actively 
      being sold, LICENSEE agrees to pay to LICENSOR a usage license fee of a 
      total of<font style="text-indent:5%"> ******* </font> (the &#147;<B>Usage License Fee</B>&#148;) in<font style="text-indent:5%"> ******* </font> according to the schedule 
      provided below in this Section. If LICENSEE exercises a License Option 
      pursuant to Section 2c for additional territories, LICENSEE agrees to pay 
      a Usage License Fee for each Product Line within each additional 
  territory.</P></TD></TR>
  <TR>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%"></TD>
    <TD vAlign=top align=left width="5%">(i) </TD>
    <TD>
      <P align=justify><B><U>For<font style="text-indent:5%"> ******* </font> Product Line: </U></B>LICENSEE will agree to 
      pay to LICENSOR a Usage License Fee of a total of<font style="text-indent:5%"> ******* </font> upon entering into this 
      Agreement, as an ongoing<font style="text-indent:5%"> ******* </font> fee payable as follows:<font style="text-indent:5%"> ******* </font>&nbsp; with the 
      understanding that if any of these quarterly payments are still remaining 
      to be paid at the end of the two year Term of this Agreement they are due 
      in full at that time, unless otherwise cancelled under Section 4.b. or 
      4.c. of this Agreement. This Usage License Fee schedule shall repeat for 
      whichever Product Line LICENSEE launches first in each additional 
      Territory upon LICENSEE exercising its option to enter each Territory as 
  per Section 2;</P></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black 
noShade SIZE=5>
<!--$$/page=--><A name=page_19></A><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="10%"  >&nbsp;</TD>
    <TD vAlign=top width="5%">(ii) </TD>
    <TD>
      <P align=justify><B><U>For All Other Product Lines: 
  </U></B><font style="text-indent:5%"> ******* </font></P></TD></TR></TABLE><BR>
<TABLE 
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; " 
cellSpacing=0 cellPadding=0 width="100%" border=0 BCLLIST>
  
  <TR>
    <TD width="5%"  >&nbsp;</TD>
    <TD vAlign=top width="5%">(c) </TD>
    <TD>
      <P align=justify><B><U>Severance Fee, if applicable. </U></B>A Usage 
      License Fee shall be paid for each Product Line that is then in production 
      and being sold, unless otherwise agreed to by the Parties. As provided for 
      in Section 2(e), LICENSEE may elect to end sales of a Product Line at its 
      sole discretion with a severance fee (&#147;<B>Severance Fee&#148;) </B>immediately 
      then due which is<font style="text-indent:5%"> ******* </font> but all other Usage License Fees are waived. If LICENSEE 
      elects to end sales of any Product Line, then any other licensing 
      provision benefits with that Product Line also end at that 
  time.</P></TD></TR></TABLE><BR>
<HR align=center width="100%" color=black noShade SIZE=5>

</BODY>

</HTML>
</TEXT>
</DOCUMENT>
